Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
about
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
description
clinical trial
@en
klinisch onderzoek
@nl
name
Immunogenicity and Safety Stud ...... jects Four to Six Years of Age
@en
type
label
Immunogenicity and Safety Stud ...... jects Four to Six Years of Age
@en
prefLabel
Immunogenicity and Safety Stud ...... jects Four to Six Years of Age
@en
P1050
P1132
P131
P1476
Immunogenicity and Safety Stud ...... r to Six Years of Age (209762)
@en
P3098
NCT01621802
P580
2012-06-21T00:00:00Z
P582
2015-07-06T00:00:00Z